Susan Lee joined Goodwin’s Life Sciences practice as a partner in their Washington, DC office. Lee advises biologics and technology companies on FDA regulatory and compliance matters, and is rankd by Legal 500 as a Next Generation Partner for life sciences and healthcare. Technology and Life Sciences partner Mitchell Bloom stated that Lee’s broad experience in FDA regulatory strategy, commercialization and issues related to corporate transactions are invaluable to the firm’s clients at all stages of the product and corporate lifecycle. Read the National Law Review article here.